Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Adriana Fantini"'
Autor:
Adriana Fantini, Luca Giulio, Andrea Delledonne, Silvia Pescina, Cristina Sissa, Sara Nicoli, Patrizia Santi, Cristina Padula
Publikováno v:
Pharmaceutics, Vol 15, Iss 1, p 129 (2022)
The greatest achievement in the advanced drug delivery field should be the optimization of non-invasive formulations for the delivery of high molecular weight compounds. Peptides, proteins, and other macromolecules can have poor membrane permeation,
Externí odkaz:
https://doaj.org/article/97a24f29594d442fb34c49b6840c057d
Publikováno v:
Pharmaceutics, Vol 12, Iss 6, p 491 (2020)
Crisaborole, a nonsteroidal phosphodiesterase 4 inhibitor, represents the first nonsteroidal medication approved for the treatment of atopic dermatitis in over a decade. In this work, crisaborole skin permeation and retention was studied in vitro fro
Externí odkaz:
https://doaj.org/article/3b8c804822b14a168175bfcbf3c9eccb
Autor:
Martina Ghezzi, Ilaria Ferraboschi, Adriana Fantini, Silvia Pescina, Cristina Padula, Patrizia Santi, Cristina Sissa, Sara Nicoli
Publikováno v:
International Journal of Pharmaceutics. 638:122911
Publikováno v:
Pharmaceutics, Vol 12, Iss 491, p 491 (2020)
Pharmaceutics
Volume 12
Issue 6
Pharmaceutics
Volume 12
Issue 6
Crisaborole, a nonsteroidal phosphodiesterase 4 inhibitor, represents the first nonsteroidal medication approved for the treatment of atopic dermatitis in over a decade. In this work, crisaborole skin permeation and retention was studied in vitro fro
Publikováno v:
International journal of pharmaceutics. 565
After application to the skin surface, a topical formulation is submitted to changes in composition produced by evaporation of volatile components, penetration of components into the skin and extraction of skin components (“vehicle metamorphosis”